The lipopolysaccharide core type of Escherichia coli O157:H7 and other non-O157 verotoxin-producing E. coli

FEMS Immunology and Medical Microbiology

Volumn 24, Issue 1, 1999, Pages 57-62

  Currie, Carol G ^a   Poxton, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Lipopolysaccharide; Lipopolysaccharide core oligosaccharide; R3 core; Shigatoxin producing E. coli; Verotoxin producing Escherichia coli

Indexed keywords

BACTERIAL TOXIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; VEROTOXIN;

ARTICLE; ESCHERICHIA COLI; IMMUNOBLOTTING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ESCHERICHIA COLI; ESCHERICHIA COLI O157; HUMANS; LIPOPOLYSACCHARIDES; MICE;

EID: 0032945367     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00007-3     Document Type: Article

References (22)

1. Le Maoult, J., Szabo, P. and Weksler, M.E. (1997) Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol. Rev. 160, 115-126.
2. Louise, C.B. and Obrig, T.G. (1992) Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60, 1536-1543.
3. Chart, H., Scotland, S.M., Willshaw, G.A. and Rowe, B. (1989) Serum antibodies to Escherichia coli serotype O157:H7 in patients with haemolytic uraemic syndrome. J. Clin. Microbiol. 27, 285-290.
4. Chart, H. and Rowe, B. (1992) Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA antibodies to lipopolysaccharide. J. Infect. 24, 257-261.
5. Schmidt, G., Jann, B. and Jann, K. (1969) Immunochemistry of R lipopolysaccharides of E. coli. Different core regions in the LPS of O group 8. Eur. J. Biochem. 10, 501-510.
6. Schmidt, G., Fromme, I. and Mayer, H. (1970) Immunochemical studies on core LPS of Enterobacteriaceae of different genera. Eur. J. Biochem. 14, 357-366.
7. Heinrichs, E., Yethon, J.A. and Whitfield, C. (1998) Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Microbiol. 29, 221-232.
8. Gibb, A.P., Barclay, G.R., Poxton, I.R. and di Padova, F. (1992) Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies. J. Infect. Dis. 166, 1051-1057.
9. Gibb, A.P. (1993) Cross reactive antibodies to LPS. PhD Thesis, University of Edinburgh.
10. Fomsgaard, A., Shand, G.H., Freudenberg, C.G., Conrad, R.S., Kronberg, G. and Hølby (1993) Antibodies from chronically infected cystic fibrosis patients react with LPS extracted by new micromethods from all serotypes of Pseudomonas aeruginosa. APMIS 101, 101-112.
11. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277, 680-685.
12. Hancock, I.C. and Poxton, I.R. (1988) Appendix 1, General Methods. In: Bacterial Cell Surface Techniques, pp. 277-281. John Wiley and Sons, Chichester.
13. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
14. Barclay, G.R. (1995) Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. In: Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy (Levin, J., Alving, C.R., Munford, R.S. and Redl, H., Eds.), pp. 263-272. Wiley-Liss, New York.
15. di Padova, F., Gram, H., Barclay, G.R., Poxton, I.R., Liehl, E. and Rietschel, E.T. (1995) Monoclonal antibodies to endotoxin core as a new approach in endotoxemia therapy. In: Novel Therapeutic Strategies in the Treatment of Sepsis (Morrison, D.C. and Ryan, R.W., Eds.), pp. 13-31. Marcel Dekker, New York.
16. Heyderman, R.S., Fitzpatrick, M.M. and Barclay, G.R. (1994) Haemolytic-uraemic syndrome. Lancet 343, 8904.
17. Smith, H.W., Green, P. and Parsell, S. (1983) Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J. Gen. Microbiol. 129, 3121-3137.
18. Cockerill, F., Beebakhee, G., Soni, R. and Sherman, P. (1996) Polysaccharide side chains are not required for attaching and effacing adhesion of Escherichia coli O157:H7. Infect. Immun. 64, 3196-3200.
19. Bilge, S.S., Vary, J.C., Dowell, S.F. and Tarr, P.I. (1996) Role of Escherichia coli O157:H7 O side chains in adherence and analysis of an rfb locus. Infect. Immun. 64, 4795-4801.
20. Nelson, D., Bathgate, A.J. and Poxton, I.R. (1991) Monoclonal antibodies as probes for detecting lipopolysaccharide expression on Escherichia coli from different growth conditions. J. Gen. Microbiol. 137, 2741-2751.
21. Radu, S., Mutalib, S.A., Rusul, G. et al. (1998) Detection of Escherichia coli O157:H7 in the beef market in Malaysia. Appl. Environ. Microbiol. 64, 1153-1156.
22. Appelmelk, B.J., An, Y.-Q., Hekker, T.A.M. et al. (1994) Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients. Microbiology 140, 1119-1124.